FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions.
about
Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study.Heat shock protein 90 inhibitors overcome the resistance to Fms-like tyrosine kinase 3 inhibitors in acute myeloid leukemiaTurning Stem Cells Bad: Generation of Clinically Relevant Models of Human Acute Myeloid Leukemia through Gene Delivery- or Genome Editing-Based ApproachesResistance to FLT3 inhibitors in acute myeloid leukemia: Molecular mechanisms and resensitizing strategies
P2860
FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions.
@en
type
label
FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions.
@en
prefLabel
FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions.
@en
P2860
P1476
FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions.
@en
P2093
Maria Larrosa-Garcia
Maria R Baer
P2860
P304
P356
10.1158/1535-7163.MCT-16-0876
P577
2017-06-01T00:00:00Z